Literature DB >> 9881378

In vitro susceptibility of Gabonese wild isolates of Plasmodium falciparum to artemether, and comparison with chloroquine, quinine, halofantrine and amodiaquine.

B Pradines1, M Mabika Mamfoumbi, D Parzy, M Owono Medang, C Lebeau, J R Mourou Mbina, J C Doury, M Kombila.   

Abstract

The in vitro activity of artemether against 63 African isolates of Plasmodium falciparum from Libreville, Gabon was evaluated using an isotopic drug susceptibility semi-microtest. The 50% inhibitory concentration (IC50) values for artemether were in a narrow range from 0.8 to 34.8 nM (mean IC50 5.0 nM) and the 95% confidence interval (CI95%) was 3.6-6.3 nM. In vitro decreased susceptibility or resistance were observed with artemether (14%), to chloroquine (90%), to quinine (32%). Isolate susceptibility to amodiaquine and halofantrine was high i.e. 100% and 98%, respectively. There was a significant positive correlation between responses to artemether and amodiaquine (r2 = 0.45, P < 0.001), artemether and chloroquine (r2 = 0.36, P < 0.001), artemether and quinine (r2 = 0.31, P < 0.001), and artemether and halofantrine (r2 = 0.19, P < 0.01). Positive correlation between these drugs suggests in vitro cross-resistance or at least common features in drug uptake and/or mode of action or resistance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881378     DOI: 10.1017/s0031182098003400

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  10 in total

1.  Differential association of Plasmodium falciparum Na+/H+ exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum.

Authors:  Stéphane Pelleau; Lionel Bertaux; Sébastien Briolant; Michael T Ferdig; Véronique Sinou; Bruno Pradines; Daniel Parzy; Ronan Jambou
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

2.  Polymorphisms in Pfmdr1, Pfcrt, and Pfnhe1 genes are associated with reduced in vitro activities of quinine in Plasmodium falciparum isolates from western Kenya.

Authors:  Jelagat Cheruiyot; Luicer A Ingasia; Angela A Omondi; Dennis W Juma; Benjamin H Opot; Joseph M Ndegwa; Joan Mativo; Agnes C Cheruiyot; Redemptah Yeda; Charles Okudo; Peninah Muiruri; Ngalah S Bidii; Lorna J Chebon; Paul O Angienda; Fredrick L Eyase; Jacob D Johnson; Wallace D Bulimo; Ben Andagalu; Hoseah M Akala; Edwin Kamau
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

3.  In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genes.

Authors:  Carolina Bustamante; Onikepe A Folarin; Grace O Gbotosho; Camila N Batista; Elieth A Mesquita; Rodrigo M Brindeiro; Amilcar Tanuri; Claudio J Struchiner; Akintunde Sowunmi; Ayoade Oduola; Dyann F Wirth; Mariano G Zalis; Christian T Happi
Journal:  J Infect Dis       Date:  2012-05-21       Impact factor: 5.226

Review 4.  Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria.

Authors:  Jane Achan; Ambrose O Talisuna; Annette Erhart; Adoke Yeka; James K Tibenderana; Frederick N Baliraine; Philip J Rosenthal; Umberto D'Alessandro
Journal:  Malar J       Date:  2011-05-24       Impact factor: 2.979

5.  Dynamic changes in genetic diversity, drug resistance mutations, and treatment outcomes of falciparum malaria from the low-transmission to the pre-elimination phase on the islands of São Tomé and Príncipe.

Authors:  Ying-An Chen; Tsen-Ju Shiu; Lien-Fen Tseng; Chien-Fu Cheng; Wei-Liang Shih; Arlindo Vicente de Assunção Carvalho; Kun-Hsien Tsai
Journal:  Malar J       Date:  2021-12-14       Impact factor: 2.979

6.  Evidence of decline of malaria in the general hospital of Libreville, Gabon from 2000 to 2008.

Authors:  Marielle Karine Bouyou-Akotet; Denise Patricia Mawili-Mboumba; Eric Kendjo; Modeste Mabika-Mamfoumbi; Edgard Brice Ngoungou; Arnaud Dzeing-Ella; Mireille Pemba-Mihindou; Euloge Ibinga; Emmanuel Efame-Eya; Tim Planche; Peter G Kremsner; Maryvonne Kombila
Journal:  Malar J       Date:  2009-12-17       Impact factor: 2.979

7.  In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon.

Authors:  Rafika Zatra; Jean Bernard Lekana-douki; Faustin Lekoulou; Ulrick Bisvigou; Edgard Brice Ngoungou; Fousseyni S Toure Ndouo
Journal:  BMC Infect Dis       Date:  2012-11-15       Impact factor: 3.090

8.  Prevalence of Plasmodium falciparum infection in pregnant women in Gabon.

Authors:  Marielle K Bouyou-Akotet; Denisa E Ionete-Collard; Modeste Mabika-Manfoumbi; Eric Kendjo; Pierre-Blaise Matsiegui; Elie Mavoungou; Maryvonne Kombila
Journal:  Malar J       Date:  2003-06-25       Impact factor: 2.979

Review 9.  CYP2C8 and antimalaria drug efficacy.

Authors:  J P Gil; E Gil Berglund
Journal:  Pharmacogenomics       Date:  2007-02       Impact factor: 2.533

10.  Differential Prevalences of Pfmdr1 Polymorphisms in Symptomatic and Asymptomatic Plasmodium falciparum Infections in Lastoursville: A Rural Area in East-Central Gabon.

Authors:  Steede Seinnat Ontoua; Lady Charlene Kouna; Sandrine Lydie Oyegue-Liabagui; Dominique Fatima Voumbo-Matoumona; Diamella Nancy Moukodoum; Romeo Karl Imboumy-Limoukou; Jean Bernard Lekana-Douki
Journal:  Infect Drug Resist       Date:  2021-07-24       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.